Skip to main content
Clinical Trials/JPRN-UMIN000035844
JPRN-UMIN000035844
Recruiting
未知

Examination of efficacy and safety treated by denosumab or zoledronate in glucocorticoid-induced osteoporosis - Efficacy and safety treated by denosumab orzoledronate in GIO

Dept. of Orthopaedic Surgery Shinshu University School of Medicine0 sites60 target enrollmentFebruary 13, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Dept. of Orthopaedic Surgery Shinshu University School of Medicine
Enrollment
60
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 13, 2019
End Date
February 11, 2024
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Dept. of Orthopaedic Surgery Shinshu University School of Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1 Patients who have taken denosumab or zoledronate before 2 Patients who are allergic to denosumab or zoledronate 3 Pregnant or breast\-feeding patients 4 Renal failure (Ccr is less than 35 mL/min) 5 Dehydrated state 6 Hypocalcemia

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
The clinical study of the safety and efficacy of docetaxel combined with ribavirin in docetaxel resistant castration resistant prostate cancer
JPRN-UMIN000015130Keio University School of Medicine, Department of Urology20
Completed
Not Applicable
A preliminary safety and efficacy evaluation of direct delivery of autologous bone marrow-derived cells in Egyptian patients with type 1 diabetes mellitusType 1 diabetes mellitusDigestive System
ISRCTN15591075Wadi EL-Neel hospital (JCI)3
Active, not recruiting
Not Applicable
A study of DoTiNurad aiming to treat hyperuricemia with CKDPatients with hyperuricemia whose renal function is in the GFR range of G1 to G4
JPRN-jRCTs061210079Wada Jun100
Not yet recruiting
Phase 1
euroEPO – Type 2 Spinocerebellar Ataxia Phase I-IIType 2 Spinocerebellar Ataxia
RPCEC00000187Center of Molecular Immunology (CIM), CIMAB34
Active, not recruiting
Phase 1
Evaluation of the safety and efficacy of the treatment of chronic wounds in diabetic foot syndrome with the use of autologous stem cells isolated from adipose tissue - within the project: Therapeutic potential of adipose-derived stem cells, proven in clinical trials and examined in vitro - rationale for banking of well characterized cells”Diabetic foot ulcerMedDRA version: 20.0 Level: LLT Classification code 10012664 Term: Diabetic foot ulcer System Organ Class: 100000004858Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
EUCTR2016-004109-15-PLMedical University of Warsaw50